Designs for phase I clinical trials with multiple courses of subjects at different doses

Fan, Shenghua K. & Wang, You-Gan (2007) Designs for phase I clinical trials with multiple courses of subjects at different doses. Biometrics, 63(3), pp. 856-864.

View at publisher

Abstract

The goal of this article is to provide a new design framework and its corresponding estimation for phase I trials. Existing phase I designs assign each subject to one dose level based on responses from previous subjects. Yet it is possible that subjects with neither toxicity nor efficacy responses can be treated at higher dose levels, and their subsequent responses to higher doses will provide more information. In addition, for some trials, it might be possible to obtain multiple responses (repeated measures) from a subject at different dose levels. In this article, a nonparametric estimation method is developed for such studies. We also explore how the designs of multiple doses per subject can be implemented to improve design efficiency. The gain of efficiency from "single dose per subject" to "multiple doses per subject" is evaluated for several scenarios. Our numerical study shows that using "multiple doses per subject" and the proposed estimation method together increases the efficiency substantially.

Impact and interest:

1 citations in Scopus
Search Google Scholar™

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 90517
Item Type: Journal Article
Refereed: Yes
Keywords: dose finding, estimation efficiency, fisher information, isotonic, regression, phase I clinical trial, toxicity, continual reassessment method, bayesian design, cancer, extension
DOI: 10.1111/j.1541-0420.2007.00772.x
ISSN: 0006-341X
Divisions: Current > QUT Faculties and Divisions > Science & Engineering Faculty
Deposited On: 18 Nov 2015 01:45
Last Modified: 18 Nov 2015 01:45

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page